From David Elin - CF Foundation <[email protected]>
Subject It's time to pass the PASTEUR Act
Date September 12, 2023 12:02 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Congress needs to hear from you!


([link removed])


([link removed])


Dear Advocate,

Congress is back in session, and we want to make sure their top priority is to
pass the PASTEUR Act ([link removed])
to bring new antibiotics to the marketplace for people with CF.


TAKE ACTION ([link removed])


Today, the CF Foundation helped bring together a diverse group of organizations on Capitol Hill to urge Congress to address antimicrobial resistance by passing the PASTEUR Act -- a bipartisan bill that will bolster a new era of antibiotic research and development to bring novel treatments into the hands of those who need them the most -- this year. Time is of the essence as antibiotic-resistant infections continue to rise not just for the CF community, but for everyone. As we deliver our message on Capitol Hill, we need your voice in the fight for new antibiotics for the CF Community. If you are as fired up as we are, make a call or send a message now to urge your members of Congress to cosponsor the PASTEUR Act.


PASS THE PASTEUR ACT ([link removed])


Thank you for lending your voice on this critical issue,

David

David T. Elin, MSW

Senior Director, Advocacy & Government Affairs




([link removed])
% link:[link removed] name="[link removed]" content="" %]
% link:[link removed] name="[link removed]" content="" %]
% link:[link removed] name="[link removed]" content="" %]
% link:[link removed] name="[link removed]" content="" %]


4550 Montgomery Avenue, Suite 1100N | Bethesda, MD 20814 US


DONATE ([link removed])


WE WILL NOT REST UNTIL WE FIND A CURE

Got this as a forward? [Sign up]([link removed]) to receive our future emails.

[Opt out]([link removed] "opt out of this mailing link") of this mailing list

Opt out ([link removed])
of all CF Foundation emails

This email was sent to [email protected].
To continue receiving our emails, add us to your address book.
Screenshot of the email generated on import

Message Analysis